Derm Cases · Dermatology / Infectious Diseases / Emergency Medicine
OSCE — antimicrobials for skin infection: cellulitis vs abscess, stewardship, and when to escalate
An 8-minute OSCE station on distinguishing cellulitis/erysipelas from abscess and non-infectious red legs, choosing empiric antibiotics and duration concepts, incision-and-drainage when indicated, and MRSA/red-flag recognition.
On this page
Study tools
Target exams
NEET-PGINICETUSMLEPLABMRCP
Prompt
An 8-minute OSCE station on distinguishing cellulitis/erysipelas from abscess and non-infectious red legs, choosing empiric antibiotics and duration concepts, incision-and-drainage when indicated, and MRSA/red-flag recognition.
Brief (to candidate)
A 45-year-old has an acutely red, hot, painful lower leg with fever. There is no fluctuance. A second patient has a tender pointing boil with central pustule. You have 8 minutes to diagnose, decide antibiotics versus drainage, and apply stewardship and safety-netting.
[7]Candidate instructions
- Differentiate cellulitis/erysipelas, abscess/furuncle, and mimics (stasis dermatitis, DVT, contact dermatitis).
- Choose empiric oral vs IV pathway using severity.
- State when incision and drainage is primary therapy.
- Apply antibiotic stewardship (duration, avoid unnecessary broad agents).
- Identify necrotising infection red flags.
Examiner checklist (mark each domain / 10)
| Domain | Key actions expected |
|---|---|
| Cellulitis vs erysipelas | Spreading dermal/subcutaneous infection; erysipelas more superficial with raised advancing edge often strep; mark borders, assess systemic features[1][2] |
| Abscess | Fluctuant collection → incision and drainage is definitive; antibiotics adjunct when systemic features, cellulitis surround, immunocompromise, or face/hand special sites per protocol[3] |
| Empiric therapy concepts | Cover Streptococcus/MSSA for typical non-purulent cellulitis; add MRSA-active agents when purulent infection, known MRSA, or local epidemiology dictates; escalate to IV if septic/rapidly progressive/unable to take oral[1][4] |
| Stewardship | Avoid prolonged antibiotics for non-infectious “red leg”; reassess 48–72 h; short evidence-based courses when responding; do not treat colonisation with endless antibiotics |
| Mimics | Bilateral chronic stasis changes ≠ bilateral cellulitis; consider DVT, lipodermatosclerosis flare, contact dermatitis, gout |
| Red flags | Pain out of proportion, crepitus, rapid progression, purple bullae, anaesthesia → necrotising fasciitis pathway (urgent surgery + broad IV therapy)[5] |
| Prevention | Treat tinea pedis/entry points; compression for venous disease once infection controlled; glycaemic control |
Model key actions
- Treat non-purulent cellulitis with appropriately targeted antibiotics and severity-based route.[1][2]
- Drain abscesses; do not rely on antibiotics alone when pus is present.[3]
- Exclude necrotising infection and common non-infectious mimics.[5]
Common errors
- Antibiotics alone for drainable abscess.
- Treating bilateral chronic stasis dermatitis as recurrent cellulitis for months.
- Missing necrotising fasciitis red flags.
- Endless broad-spectrum therapy without reassessment.
- Ignoring portal of entry (tinea, ulcer).
References7ShowHide
- [1]Rrapi R, Chand S, Kroshinsky D. Cellulitis: A Review of Pathogenesis, Diagnosis, and Management. The Medical clinics of North America, 2021.PMID 34059247
- [2]Holt RIG, Cockram CS, Ma RCW, et al. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment. Diabetologia, 2024.PMID 38374451
- [3]Hatlen TJ, Miller LG. Staphylococcal Skin and Soft-Tissue Infections. Infectious disease clinics of North America, 2021.PMID 33303329
- [4]Yosipovitch G, Nedorost ST, Silverberg JI, et al. Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management. American Journal of Clinical Dermatology, 2023.PMID 36800152
- [5]Gardini G, Gregori N, Matteelli A, et al. Mycobacterial skin infection. Current Opinion in Infectious Diseases, 2022.PMID 35067521
- [6]Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology, 2024.PMID 38300170
- [7]Shu Z, Cao J, Li H, et al. Efficacy and safety of first- and second-line antibiotics for cellulitis and erysipelas: a network meta-analysis of randomized controlled trials Arch Dermatol Res, 2024.PMID 39240378